To this end, we performed immunohistochemical staining of USP26 and pSMAD2, with antibodies validated for immunohistochemistry, on glioblastoma tissue microarrays containing samples from 36 patients (Figs EV5A, and 5A and B). The gene discussed is USP26; the disease is glioblastoma.